MENU
+Compare
ALVO
Stock ticker: NASDAQ
AS OF
Dec 3 closing price
Price
$4.64
Change
+$0.04 (+0.87%)
Capitalization
1.45B

ALVO Alvotech Forecast, Technical & Fundamental Analysis

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally... Show more

ALVO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ALVO with price predictions
Nov 28, 2025

ALVO's RSI Indicator climbs out of oversold territory

The RSI Indicator for ALVO moved out of oversold territory on November 21, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 29 similar instances when the indicator left oversold territory. In of the 29 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Moving Average Convergence Divergence (MACD) for ALVO just turned positive on November 21, 2025. Looking at past instances where ALVO's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ALVO advanced for three days, in of 250 cases, the price rose further within the following month. The odds of a continued upward trend are .

ALVO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 21, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ALVO as a result. In of 112 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 10-day moving average for ALVO crossed bearishly below the 50-day moving average on October 30, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALVO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ALVO entered a downward trend on November 13, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (17.312). P/E Ratio (20.174) is within average values for comparable stocks, (72.847). ALVO's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.956). ALVO has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (2.352) is also within normal values, averaging (55.504).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ALVO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALVO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

View a ticker or compare two or three
ALVO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ALVO is expected to report earnings to fall 118.72% to -8 cents per share on April 01

Alvotech ALVO Stock Earnings Reports
Q4'25
Est.
$-0.09
Q3'25
Beat
by $0.50
Q2'25
Beat
by $0.50
Q1'25
Beat
by $0.32
Q4'24
Missed
by $0.15
The last earnings report on November 12 showed earnings per share of 46 cents, beating the estimate of -2 cents. With 1.23M shares outstanding, the current market capitalization sits at 1.45B.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
9, rue de Bitbourg
Phone
+352 4224500
Employees
999
Web
https://www.alvotech.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
REMYX20.99N/A
N/A
Russell Inv Emerging Markets Y
AVLIX8.71N/A
N/A
American Century Value I
SSDIX38.45N/A
N/A
DWS Small Cap Growth Inst
SFGCX15.34N/A
N/A
NAA World Equity Income C
HILCX24.23N/A
N/A
Hartford International Value C

ALVO and Stocks

Correlation & Price change

A.I.dvisor tells us that ALVO and EBS have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALVO and EBS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALVO
1D Price
Change %
ALVO100%
-4.96%
EBS - ALVO
31%
Poorly correlated
+0.56%
CRON - ALVO
27%
Poorly correlated
-1.00%
PAHC - ALVO
26%
Poorly correlated
-0.10%
VTRS - ALVO
22%
Poorly correlated
+0.09%
ACB - ALVO
22%
Poorly correlated
-0.99%
More

Groups containing ALVO

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALVO
1D Price
Change %
ALVO100%
-4.96%
Pharmaceuticals: Generic
industry (213 stocks)
23%
Poorly correlated
+0.76%